Muscle histopathology in children with spastic cerebral palsy receiving botulinum toxin type A.

Muscle & nerve 2016 Vol.53(3) p. 407-14

Valentine J, Stannage K, Fabian V, Ellis K, Reid S, Pitcher C, Elliott C

관련 도메인

Abstract

[INTRODUCTION] Botulinum toxin A (BoNTA) is routine treatment for hypertonicity in children with cerebral palsy (CP).

[METHODS] This single-blind, prospective, cross-sectional study of 10 participants (mean age 11 years 7 months) was done to determine the relationship between muscle histopathology and BoNTA in treated medial gastrocnemius muscle of children with CP. Open muscle biopsies were taken from medial gastrocnemius muscle and vastus lateralis (control) during orthopedic surgery.

[RESULTS] Neurogenic atrophy in the medial gastrocnemius was seen in 6 participants between 4 months and 3 years post-BoNTA. Type 1 fiber loss with type 2 fiber predominance was significantly related to the number of BoNTA injections (r = 0.89, P < 0.001).

[CONCLUSIONS] The impact of these changes in muscle morphology on muscle function in CP is not clear. It is important to consider rotating muscle selection or injection sites within the muscle or allowing longer time between injections.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 2

MeSH Terms

Botulinum Toxins, Type A; Cerebral Palsy; Child; Cross-Sectional Studies; Female; Humans; Male; Microscopy, Electron; Muscle, Skeletal; Neuromuscular Agents; Reproducibility of Results; Single-Blind Method

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문